Lexicon Pharmaceuticals Inc
LXRX
Company Profile
Business description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Contact
2445 Technology Forest Boulevard
11th Floor
The WoodlandsTX77381
USAT: +1 281 863-3000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
81
Stocks News & Analysis
stocks
Weak investor sentiment for cheap ASX
Earnings growth maintained despite turbulent market conditions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,000.60 | 41.90 | 0.47% |
| CAC 40 | 8,062.31 | 86.19 | 1.08% |
| DAX 40 | 24,401.70 | 410.43 | 1.71% |
| Dow JONES (US) | 49,298.25 | 356.35 | 0.73% |
| FTSE 100 | 10,219.11 | 144.82 | -1.40% |
| HKSE | 26,080.31 | 181.70 | 0.70% |
| NASDAQ | 25,326.13 | 258.33 | 1.03% |
| Nikkei 225 | 59,513.12 | 228.20 | 0.38% |
| NZX 50 Index | 13,179.90 | 144.20 | 1.11% |
| S&P 500 | 7,259.22 | 58.47 | 0.81% |
| S&P/ASX 200 | 8,778.80 | 43.80 | 0.50% |
| SSE Composite Index | 4,159.60 | 47.45 | 1.15% |